4.7 Article

Structure-Related Mode-of-Action Differences of Anticancer Organoruthenium Complexes with β-Diketonates

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 58, 期 9, 页码 3984-3996

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.5b00288

关键词

-

资金

  1. Slovenian Research Agency (ARRS) [P1-0175]
  2. COST action [CM1105]
  3. Junior Researcher Grant

向作者/读者索取更多资源

A series of organoruthenium(II) chlorido complexes with fluorinated O,O-ligands [(eta(6)-p-cymene)Ru(F3C-acac-Ar)Cl] (1a-6a) and their respective 1,3,5-triaza-7-phosphaadamantane (pta) derivatives [(eta(6)-p-cymene)Ru(F3C-acac-Ar)pta]PF6 (1b-6b) were synthesized and fully characterized in both solution and solid state. All complexes were inactive against nonmalignant keratinocytes but displayed variable activity against cancer cell models (ovarian, osteosarcoma). Compounds with a ligand containing the 4-chlorophenyl substituent (6a and 6b) exhibited the strongest anticancer effects. Despite a marginally lower cellular Ru accumulation compared to the chlorido complexes, pta analogues showed higher activity especially in the osteosarcoma model. Reduction of glutathione levels by buthionine sulfoximine (BSO) significantly enhanced the activity of all compounds with the most pronounced effects being observed for the pta series resulting in IC50 values down to the nanomolar range. While all chlorido complexes potently induce reactive oxygen species, DNA damage, and apoptosis, the respective pta compounds widely lacked ROS production but blocked cell cycle progression in G0/G1 phase.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation

Dina Baier, Beatrix Schoenhacker-Alte, Mate Rusz, Christine Pirker, Thomas Mohr, Theresa Mendrina, Dominik Kirchhofer, Samuel M. Meier-Menches, Katharina Hohenwallner, Martin Schaier, Evelyn Rampler, Gunda Koellensperger, Petra Heffeter, Bernhard Keppler, Walter Berger

Summary: Cellular energy metabolism is reprogrammed in cancer cells, leading to resistance against ruthenium-based chemotherapy drug BOLD-100 through enhanced glycolytic activity, increased lysosomal compartment, and defective downstream autophagy execution. Combining 2-deoxy-D-glucose with BOLD-100 reverses this resistance by inducing synergistic cell death and disrupting autophagy, suggesting glycolysis as a potential target to enhance BOLD-100 anticancer activity.

PHARMACEUTICS (2022)

Article Pharmacology & Pharmacy

Metal(II) Complexes of the Fluoroquinolone Fleroxacin: Synthesis, Characterization and Biological Profile

Alexandra Kostelidou, Franc Perdih, Jakob Kljun, Foteini Dimou, Stavros Kalogiannis, Iztok Turel, George Psomas

Summary: A series of complexes of divalent transition metals with the quinolone antibacterial agent fleroxacin were prepared and characterized. The complexes showed higher antibacterial activity than free quinolone and exhibited tight binding to serum albumin and DNA.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Kinetic Characterization of Cerium and Gallium Ions as Inhibitors of Cysteine Cathepsins L, K, and S

Marko Novinec, Primoz Bembic, Milica Jankovic, Marija Kisilak, Jakob Kljun, Iztok Turel

Summary: Heavy metal ions, such as gallium and cerium, can inhibit the activity of human papain-like cysteine endopeptidases, while zinc and lead ions are known inhibitors of thiol enzymes. The inhibition constants of Ga3+, Ce3+, and Ce4+ ions are comparable to Zn2+ ions, indicating their potential as cysteine cathepsin inhibitors. These ions also inhibit the degradation of elastin, suggesting their possible application in treating inflammatory diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Novel Organoruthenium(II) Complex C1 Selectively Inhibits Butyrylcholinesterase without Side Effects on Neuromuscular Transmission

Tomaz Trobec, Monika C. Zuzek, Kristina Sepcic, Jerneja Kladnik, Iztok Turel, Robert Frangez

Summary: Butyrylcholinesterase (BChE) is a therapeutic target for Alzheimer's disease. The organoruthenium(II) complex C1 was designed to selectively inhibit horse serum BChE. C1 showed no significant effect on nerve-evoked contractions but decreased the amplitude of miniature end-plate potentials (MEPP) and shortened the half-decay time of MEPPs and end-plate potentials (EPP). The results suggest a weak inhibitory effect on muscle-type nicotinic acetylcholine receptors (nAChR), but do not significantly affect neuromuscular transmission and skeletal muscle contraction.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Multidisciplinary

Copper(ii) and silver(i) complexes with dimethyl 6-(pyrazine-2-yl)pyridine-3,4-dicarboxylate (py-2pz): the influence of the metal ion on the antimicrobial potential of the complex

Tina P. Andrejevic, Ivana Aleksic, Jakob Kljun, Marta Pockaj, Matija Zlatar, Sandra Vojnovic, Jasmina Nikodinovic-Runic, Iztok Turel, Milos I. Djuran, Biljana D. Glisic

Summary: Dimethyl 6-(pyrazine-2-yl)pyridine-3,4-dicarboxylate (py-2pz) was used as a ligand to synthesize new copper(II) and silver(I) complexes. The structures of the complexes were determined by single crystal X-ray diffraction analysis, revealing the bidentate coordination mode of py-2pz to the metal ions. Silver(I) complexes showed good antimicrobial activity against bacteria and fungi. The binding affinity of the complexes with DNA and protein was studied to understand their antimicrobial mechanism. The copper(II) complexes exhibited biomimetic catalytic activity.

RSC ADVANCES (2023)

Article Biochemistry & Molecular Biology

Exploring pta Alternatives in the Development of Ruthenium-Arene Anticancer Compounds

Jakob Kljun, Mihaela Rebernik, Lucia M. Balsa, Jerneja Kladnik, Uros Rapus, Tomaz Trobec, Kristina Sepcic, Robert Frangez, Ignacio E. Leon, Iztok Turel

Summary: Organoruthenium pyrithione complexes, such as [(eta(6)-p-cymene)Ru(pyrithionato)(pta)]PF6, show promise as a new class of anticancer drugs. Our study focuses on finding alternatives to the pta ligand and discovering new structural elements to improve the biological properties of ruthenium anticancer drugs. By replacing the pta ligand with different phosphine, phosphite, and arsine ligands, we identified improved inhibitory potency against the enzyme glutathione S-transferase, as well as investigated cytotoxicity in breast, bone, and colon cancers.

MOLECULES (2023)

Article Pharmacology & Pharmacy

Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes-A More Selective Anticancer Treatment?

Yvonne Lerchbammer-Kreith, Michaela Hejl, Petra Vician, Michael A. Jakupec, Walter Berger, Mathea S. Galanski, Bernhard K. Keppler

Summary: Based on their drug delivery properties and activity against tumors, PAMAM dendrimers were combined with platinum(IV) complexes to improve anticancer treatment. The conjugates showed faster reduction behavior compared to the platinum(IV) complexes and exhibited significantly increased cytotoxic activity in human cell lines. In vivo experiments demonstrated tumor growth inhibition and prolonged animal survival.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Cannabimimetic N-Stearoylethanolamine as Double-Edged Sword in Anticancer Chemotherapy: Proapoptotic Effect on Tumor Cells and Suppression of Tumor Growth versus Its Bio-Protective Actions in Complex with Polymeric Carrier on General Toxicity of Doxorubicin In Vivo

Rostyslav Panchuk, Nadiya Skorokhyd, Vira Chumak, Lilya Lehka, Halyna Kosiakova, Tetyana Horid'ko, Iehor Hudz, Nadiya Hula, Anna Riabtseva, Nataliya Mitina, Alexander Zaichenko, Petra Heffeter, Walter Berger, Rostyslav Stoika

Summary: This study discovered the pro-apoptotic effects of synthetic cannabimimetic N-stearoylethanolamine (NSE) on various cancer cell lines, including drug-resistant models. The study also synthesized a complex of NSE with a polymeric carrier, which enhanced the anticancer activity of doxorubicin and prevented its adverse effects in mice. Overall, the novel pharmaceutical formulation of NSE showed bi-functionality by promoting apoptosis in cancer cells and enhancing the therapeutic activity of doxorubicin while minimizing side effects.

PHARMACEUTICS (2023)

Article Chemistry, Multidisciplinary

Multiparametric Tissue Characterization Utilizing the Cellular Metallome and Immuno-Mass Spectrometry Imaging

Martin Schaier, Sarah Theiner, Dina Baier, Gabriel Braun, Walter Berger, Gunda Koellensperger

Summary: In this study, a workflow combining low-dispersion laser ablation with inductively coupled plasma time-of-flight mass spectrometry (LA-ICP-TOFMS) was presented, enabling spatial single-cell metallomics in tissue to decode cellular heterogeneity. The toolbox of single-cell metallomics was expanded by integrating the concepts of imaging mass cytometry (IMC) to utilize metal-labeled antibodies for cellular tissue profiling.

JACS AU (2023)

Article Cell Biology

Intracellular remodeling associated with endoplasmic reticulum stress modifies biomechanical compliance of bladder cells

Livia Gruber, Maximilian Jobst, Endre Kiss, Martina Karasova, Bernhard Englinger, Walter Berger, Giorgia Del Favero

Summary: Bladder cells rely on the cytoskeletal network and endoplasmic reticulum (ER) to maintain mechanical stability. The rearrangement of ER can lead to changes in cellular mechanical properties.

CELL COMMUNICATION AND SIGNALING (2023)

Article Chemistry, Multidisciplinary

Reactions of Medicinal Gold Compounds with Cathepsin B Explored through Electrospray Mass Spectrometry Measurements

Andrea Geri, Lara Massai, Marko Novinec, Iztok Turel, Luigi Messori

Summary: Medicinal gold compounds exert their pharmacological effects by binding to protein targets. In this study, the reactions between seven representative gold compounds and the cysteine protease cathepsin B were explored, revealing strong interactions with the free cysteine in the enzyme. The findings suggest that the chemical nature of the gold compound plays a significant role in its interaction with proteins.

CHEMPLUSCHEM (2023)

Article Cell Biology

Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells

Alexander Ries, Astrid Slany, Christine Pirker, Johanna C. C. Mader, Doris Mejri, Thomas Mohr, Karin Schelch, Daniela Flehberger, Nadine Maach, Muhammad Hashim, Mir Alireza Hoda, Balazs Dome, Georg Krupitza, Walter Berger, Christopher Gerner, Klaus Holzmann, Michael Grusch

Summary: In this study, novel hTERT-transduced mesothelial cell and Meso-CAF models were generated and characterized, and their impact on PM cell growth was investigated.
Article Chemistry, Inorganic & Nuclear

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs

Alexander Kastner, Theresa Mendrina, Florian Bachmann, Walter Berger, Bernhard K. Keppler, Petra Heffeter, Christian R. Kowol

Summary: In this study, oxaliplatin(iv)-based complexes were developed as platinum(iv) prodrugs to release aspirin, which has shown antitumor activity against colon cancer. The newly synthesized complex demonstrated increased reduction stability compared to a cisplatin analog and exhibited desired prodrug properties in cell culture. A derivative with albumin-binding properties showed improved pharmacokinetics and tumor accumulation, leading to enhanced antitumor activity and overall survival in tumor-bearing mice.

INORGANIC CHEMISTRY FRONTIERS (2023)

Correction Biochemistry & Molecular Biology

Zinc Pyrithione is a Potent Inhibitor of PLPro and Cathepsin L Enzymes with Ex Vivo Inhibition of SARS-CoV-2 Entry and Replication (vol 37, pg 2158, 2022)

Jerneja Kladnik, Ana Dolinar, Jakob Kljun, David Perea, Judith Grau-Exposito, Meritxell Genesca, Marko Novinec, Maria J. Buzon, Iztok Turel

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)

暂无数据